Pfizer Inc.
RSV F protein mutants
Last updated:
Abstract:
The present disclosure relates to RSV F protein mutants, nucleic acids or vectors encoding a RSV F protein mutant, compositions comprising a RSV F protein mutant or nucleic acid, and uses of the RSV F protein mutants, nucleic acids or vectors, and compositions.
Status:
Grant
Type:
Utility
Filling date:
8 Jan 2019
Issue date:
3 Nov 2020